Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Impax Laboratories Inc (IPXL)  
$6.76 0.55 (8.86%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 159,210,000
Market Cap: 1.08(B)
Last Volume: 2,204,422 Avg Vol: 2,198,299
52 Week Range: $1.78 - $6.34
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Amneal Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company engaging in developing, manufacturing, marketing and distributing generic and branded pharmaceutical products across an array of dosage forms and therapeutic areas. Co. has three reportable segments: Generics, which includes various product families covering a range of dosage forms and delivery systems; Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders; and AvKARE, which provides pharmaceuticals, medical and surgical products, and services.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 215
  Page 3 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Reasons Bryan M. Chief Financial Officer   •       –      –    2017-05-14 4 D $17.65 $12,443 D/D (705) 104,348     -
   Nornhold Jeffrey SVP, Technical Operations   •       –      –    2017-05-14 4 D $17.65 $8,860 D/D (502) 88,967     -
   Schlossberg Mark A SVP and General Counsel   •       –      –    2017-05-14 4 D $17.65 $57,098 D/D (3,235) 101,944     -
   Nestor Michael President, Impax Specialty   •       –      –    2017-05-14 4 D $17.65 $52,985 D/D (3,002) 112,166     -
   Nestor Michael President, Impax Specialty   •       –      –    2017-05-12 4 S $17.11 $11,977 D/D (700) 115,168     -
   Nornhold Jeffrey SVP, Technical Operations   •       –      –    2017-03-02 4 A $0.00 $0 D/D 17,317 89,469     -
   Nestor Michael President, Impax Specialty   •       –      –    2017-03-02 4 A $0.00 $0 D/D 23,272 115,868     -
   Reasons Bryan M. Chief Financial Officer   •       –      –    2017-03-02 4 A $0.00 $0 D/D 23,272 105,053     -
   Boothe Douglas President, Generics Division   •       –      –    2017-03-02 4 A $0.00 $0 D/D 23,272 85,872     -
   Schlossberg Mark A SVP and General Counsel   •       –      –    2017-03-02 4 A $0.00 $0 D/D 23,272 105,179     -
   Schlossberg Mark A SVP and General Counsel   •       –      –    2017-02-26 4 D $14.05 $84,497 D/D (6,014) 81,907     -
   Nestor Michael President, Impax Specialty   •       –      –    2017-02-26 4 D $14.05 $78,596 D/D (5,594) 92,596     -
   Reasons Bryan M. Chief Financial Officer   •       –      –    2017-02-26 4 D $14.05 $80,296 D/D (5,715) 81,781     -
   Nornhold Jeffrey SVP, Technical Operations   •       –      –    2017-02-26 4 D $14.05 $60,429 D/D (4,301) 72,152     -
   Buchi J Kevin Director   –       •      –    2016-11-23 4 A $0.00 $0 D/D 8,020 8,020     -
   Nornhold Jeffrey SVP, Technical Operations   •       –      –    2016-10-26 4 D $21.35 $36,167 D/D (1,694) 76,453     -
   Reasons Bryan M. Chief Financial Officer   •       –      –    2016-10-26 4 D $21.35 $25,812 D/D (1,209) 87,496     -
   Nornhold Jeffrey SVP, Technical Operations   •       –      –    2016-10-25 4 D $21.80 $39,872 D/D (1,829) 78,147     -
   Boothe Douglas President, Generics Division   •       –      –    2016-08-30 4 A $0.00 $0 D/D 62,600 62,600     -
   Benet Leslie Z Director   –       •      –    2016-08-24 4 GD $0.00 $0 D/D 12,025 18,108     -
   Bierly Rick Director   –       •      –    2016-08-19 4 A $0.00 $0 D/D 4,895 4,895     -
   Benet Leslie Z Director   –       •      –    2016-08-15 4 S $22.81 $230,199 D/D (10,092) 30,133     -
   Benet Leslie Z Director   –       •      –    2016-08-15 4 OE $6.55 $131,000 D/D 20,000 40,225     -
   Nestor Michael President, Impax Specialty   •       –      –    2016-08-15 4 D $0.00 $0 D/D (24,906) 98,190     -
   Schlossberg Mark A SVP and General Counsel   •       •      –    2016-05-23 4 D $32.12 $35,171 D/D (1,095) 87,921     -
  215 Records found
  1  2  3  4  5  6  7  8  9   
  Page 3 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us